155 related articles for article (PubMed ID: 20509277)
21. Differential effects of pioglitazone on metabolic parameters in newly diagnosed, drug-naïve Japanese patients with type 2 diabetes with or without metabolic syndrome.
Kutoh E
Endocr Res; 2010; 35(3):118-27. PubMed ID: 20712426
[TBL] [Abstract][Full Text] [Related]
22. C-peptide and its correlation to parameters of insulin resistance in the metabolic syndrome.
Banu S; Jabir NR; Manjunath CN; Shakil S; Kamal MA
CNS Neurol Disord Drug Targets; 2011 Dec; 10(8):921-7. PubMed ID: 22229322
[TBL] [Abstract][Full Text] [Related]
23. Metabolic syndrome--risk factors for atherosclerosis and diabetes.
Mihic M; Modi P
Curr Diabetes Rev; 2008 May; 4(2):122-8. PubMed ID: 18473759
[TBL] [Abstract][Full Text] [Related]
24. Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM.
Lehto S; Rönnemaa T; Haffner SM; Pyörälä K; Kallio V; Laakso M
Diabetes; 1997 Aug; 46(8):1354-9. PubMed ID: 9231662
[TBL] [Abstract][Full Text] [Related]
25. Metabolic syndrome is associated with extension of coronary artery disease in patients with non-ST segment elevation acute coronary syndromes.
Birhan Yilmaz M; Guray U; Guray Y; Altay H; Demirkan B; Caldir V; Cay S; Refiker ME; Sasmaz H; Korkmaz S
Coron Artery Dis; 2005 Aug; 16(5):287-92. PubMed ID: 16000886
[TBL] [Abstract][Full Text] [Related]
26. The relationship between metabolic syndrome and target organ damage in Ghanaian with stage-2 hypertension.
Bello-Rodriguez BM; Sanchez-Cruz G; Delgado-Bustillo F; Asiama G
Ghana Med J; 2013 Dec; 47(4):189-96. PubMed ID: 24669025
[TBL] [Abstract][Full Text] [Related]
27. High Prevalence of Vitamin D Deficiency and Correlation of Serum Vitamin D with Cardiovascular Risk in Patients with Metabolic Syndrome.
Alkhatatbeh MJ; Abdul-Razzak KK; Khasawneh LQ; Saadeh NA
Metab Syndr Relat Disord; 2017 Jun; 15(5):213-219. PubMed ID: 28346853
[TBL] [Abstract][Full Text] [Related]
28. Validation of metabolic syndrome score by confirmatory factor analysis in children and adults and prediction of cardiometabolic outcomes in adults.
Viitasalo A; Lakka TA; Laaksonen DE; Savonen K; Lakka HM; Hassinen M; Komulainen P; Tompuri T; Kurl S; Laukkanen JA; Rauramaa R
Diabetologia; 2014 May; 57(5):940-9. PubMed ID: 24463933
[TBL] [Abstract][Full Text] [Related]
29. Association between gamma-glutamyl transpeptidase activity and status of disorders constituting insulin resistance syndrome.
Yokoyama H; Moriya S; Homma Y; Ogawa T
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):22S-25S. PubMed ID: 12960502
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G
Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
[TBL] [Abstract][Full Text] [Related]
31. High fasting plasma insulin is an indicator of coronary heart disease in non-insulin-dependent diabetic patients and nondiabetic subjects.
Rönnemaa T; Laakso M; Pyörälä K; Kallio V; Puukka P
Arterioscler Thromb; 1991; 11(1):80-90. PubMed ID: 1988007
[TBL] [Abstract][Full Text] [Related]
32. [Prevalence of cardiovascular risk factors in coronary heart disease patients with different low-density lipoprotein phenotypes].
Slapikas R; Luksiene D; Slapikiene B; Babarskiene MR; Grybauskiene R; Linoniene L
Medicina (Kaunas); 2005; 41(11):925-31. PubMed ID: 16333215
[TBL] [Abstract][Full Text] [Related]
33. Erosive esophagitis associated with metabolic syndrome, impaired liver function, and dyslipidemia.
Loke SS; Yang KD; Chen KD; Chen JF
World J Gastroenterol; 2013 Sep; 19(35):5883-8. PubMed ID: 24124334
[TBL] [Abstract][Full Text] [Related]
34. Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial.
Scott R; Donoghoe M; Watts GF; O'Brien R; Pardy C; Taskinen MR; Davis TM; Colman PG; Manning P; Fulcher G; Keech AC;
Cardiovasc Diabetol; 2011 Nov; 10():102. PubMed ID: 22104275
[TBL] [Abstract][Full Text] [Related]
35. A Retrospective Study in Adults with Metabolic Syndrome: Diabetic Risk Factor Response to Daily Consumption of Agaricus bisporus (White Button Mushrooms).
Calvo MS; Mehrotra A; Beelman RB; Nadkarni G; Wang L; Cai W; Goh BC; Kalaras MD; Uribarri J
Plant Foods Hum Nutr; 2016 Sep; 71(3):245-51. PubMed ID: 27193019
[TBL] [Abstract][Full Text] [Related]
36. Coronary heart disease risk factor profiles in black patients with non-insulin-dependent diabetes mellitus: paradoxic patterns.
Banerji MA; Lebovitz HE
Am J Med; 1991 Jul; 91(1):51-8. PubMed ID: 1858830
[TBL] [Abstract][Full Text] [Related]
37. [Homocystein serum levels and lipid parameters in children with atherosclerosis risk factors].
Sierakowska-Fijałek A; Kaczmarek P; Pokoca L; Smorag I; Wosik-Erenbek M; Baj Z
Pol Merkur Lekarski; 2007 Feb; 22(128):146-9. PubMed ID: 17598661
[TBL] [Abstract][Full Text] [Related]
38. Weight, the metabolic syndrome, and coronary heart disease in type 2 diabetes: associations among a national French sample of adults with diabetes-the ENTRED study.
Hillier TA; Fosse S; Balkau B; Simon D; Eschwège E; Fagot-Campagna A
J Cardiometab Syndr; 2006; 1(5):318-25. PubMed ID: 17679788
[TBL] [Abstract][Full Text] [Related]
39. Physical activity, metabolic factors, and the incidence of coronary heart disease and type 2 diabetes.
Wannamethee SG; Shaper AG; Alberti KG
Arch Intern Med; 2000 Jul; 160(14):2108-16. PubMed ID: 10904453
[TBL] [Abstract][Full Text] [Related]
40. Low HDL-cholesterol: a component of the metabolic syndrome only in the presence of fasting hypertriglyceridemia in type 2 diabetic patients.
Bo S; Cavallo-Perin P; Gentile L; Repetti E; Pagano G
Diabetes Metab; 2001 Feb; 27(1):31-5. PubMed ID: 11240443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
